enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026
enGene Holdings Inc. reported fresh preliminary data this morning from the pivotal cohort of its Phase 2 LEGEND trial of detalimogene voraplasmid in high‑risk,…




![Plug Power (PLUG) Today: Q3 Results Set the Stage for a $275M Liquidity Pivot, Data‑Center Push, and Fresh Analyst Calls [Nov 11, 2025] Plug Power (PLUG) Today: Q3 Results Set the Stage for a $275M Liquidity Pivot, Data‑Center Push, and Fresh Analyst Calls [Nov 11, 2025]](https://ts2.tech/wp-content/uploads/2025/11/Plug-Power-Inc.-PLUG-1-1024x683.jpg)












